BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rahimi R, Hosseini SY, Fattahi MR, Sepehrimanesh M, Safarpour A, Malekhosseini SA, Nejabat M, Khodadad M, Ardebili M. YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy. Hepat Mon 2015;15:e27120. [PMID: 26300928 DOI: 10.5812/hepatmon.27120v2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Silva RJS, do Nascimento RS, Oliveira-Neto JAJ, Silva FQ, Piauiense JNF, Gomes CM, Pinheiro LML, Resque RL, Pinho JRR, Kupek E, Fischer B, Machado LFA, Martins LC, Lemos JAR, Oliveira-Filho AB. Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region. Viruses 2021;13:1380. [PMID: 34372586 DOI: 10.3390/v13071380] [Reference Citation Analysis]
2 Orfanidou A, Papatheodoridis GV, Cholongitas E. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts. Liver Int 2021;41:1448-61. [PMID: 33656809 DOI: 10.1111/liv.14860] [Reference Citation Analysis]
3 Mansour-Ghanaei F, Joukar F, Naghipour M, Hassanipour S, Yeganeh S, Sepehrimanesh M, Fathalipour M. Epidemiologic profile of viral hepatitis B and C in North of Iran: results from PERSIAN Guilan Cohort Study (PGCS). BMC Res Notes 2021;14:59. [PMID: 33568187 DOI: 10.1186/s13104-021-05474-2] [Reference Citation Analysis]
4 Ma Y, Yuan Y, Ma X, Tang B, Hu X, Feng J, Tian L, Ji Y, Dou X. Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy. Exp Ther Med 2016;12:847-53. [PMID: 27446286 DOI: 10.3892/etm.2016.3365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wu L, Zhou J, Cai Q, Huang Y, Xie D, Gao Z, Deng H. Liver Fibrosis is Associated with NAFLD Activity Score in Chronic Hepatitis B Patients with Liver Steatosis. Hepat Mon 2018;In Press. [DOI: 10.5812/hepatmon.84182] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Hosseini Khorami SH, Nejatollahi F, Davarpanah MA. Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection. Hepat Mon 2018;18. [DOI: 10.5812/hepatmon.60377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 de Campos Albuquerque I, Sousa MT, Santos MD, Nunes JD, Moraes MJ, Gomes-Gouvêa MS, Pinho JR, Carrilho FJ, Fonseca LM, de Sousa Paiva Ferreira A. Mutation in the S gene a determinant of the hepatitis B virus associated with concomitant HBsAg and anti-HBs in a population in Northeastern Brazil. J Med Virol 2017;89:458-62. [PMID: 27486854 DOI: 10.1002/jmv.24653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]